Brief: China NT Pharma Sees Net Loss Attributable Of RMB35-37 Mln For Ten Months
08/01/2025 10:19
Jan 8 (Reuters) - China NT Pharma Group Co Ltd
1011.HK :
* SEES NET LOSS ATTRIBUTABLE RMB35.0 MILLION AND RMB37.0
MILLION
FOR TEN MONTHS ENDED 31 OCT
* EXPECTED RESULT DUE TO ABSENCE OF LOSS FROM MANUFACTURING
AND
SALE OF PROPRIETARY PHARMA PRODUCTS BUSINESS IN 10 MONTHS
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY